onc Videos

Videos

Videos

Strategies for Treating Patients With Multiple Myeloma in Early Relapse

05/02/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting in New York, New York, Joseph Mikhael, MD, shared strategies for treating patients with multiple myeloma in early relapse.

At the 2023 Great Debates &...

05/02/2023

Oncology

Neil Horowitz, MD, Dana-Farber Cancer Institute, Boston, MA

Videos

Concurrent Chemoradiation for Locally Advanced Vulvar Cancers

05/02/2023

At the SGO Annual Meeting on Women’s Cancer, Neil Horowitz, MD, discusses the efficacy of concurrent gemcitabine-cisplatin and intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the vulva.

At the SGO Annual Meeting on...

05/02/2023

Oncology

Melissa Alsina, MD, Moffitt Cancer Center

Videos

Looking to the Future of Treatment Options for Patients With Multiple Myeloma

05/02/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Melissa Alsina, MD, discussed possible future treatment options for patients with myeloma.

At the 2023 Great Debates &...

05/02/2023

Oncology

Saad Usmani Memorial Sloan Kettering Cancer Center

Videos

Novel and Cellular Therapies to Treat Patients With R/R Multiple Myeloma

05/02/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Saad Z. Usmani, MD, MBA, FACP, discussed novel and cellular therapies used to treat relapsed/refractory multiple myeloma, including but not...

At the 2023 Great Debates &...

05/02/2023

Oncology

Jyoti Mayadev, MD, University of California - San Diego, CA

Videos

Efficacy and Safety of Chemoradiation for Patients With Stage IB3 Cervical Cancer

04/28/2023

At the SGO Annual Meeting on Women’s Cancer, Jyoti Mayadev, MD, discusses best practices for treating patients with IB3 cervical cancer, focusing on the benefits of chemoradiation treatment.

At the SGO Annual Meeting on...

04/28/2023

Oncology

Paolo Tarantino, MD, Dana-Farber Cancer Institute, Boston, MA

Videos

Genomic Differences Among HER2-Low, HER2-Zero, and HER2-Positive Breast Cancer

04/28/2023

Paolo Tarantino, MD, discusses advancements in genomic study and treatment efficacy for HER2-Low, HER2-Zero, and HER2-Positive breast cancers.

Paolo Tarantino, MD, discusses...

04/28/2023

Oncology

Videos

Benefits of HSCT for Patients With AML With MRD After Initial Therapy

04/27/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting in New York, New York, Andrew Artz, MD, participated in a debate about the benefits of hematopoietic stem cell transplantation among patients with AML with MRD after...

At the 2023 Great Debates &...

04/27/2023

Oncology

Videos

Effective Risk Stratification for Patients With Myelodysplastic Syndromes

04/26/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Amer Zeidan, MBBS, MHS, discussed effective risk stratification among patients with myelodysplastic syndromes.

At the 2023 Great Debates &...

04/26/2023

Oncology

Videos

Considering MRD Before HSCT for Patients With Acute Myeloid Leukemia

04/25/2023

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, Richard Stone, MD, debated the role of measurable residual disease when considering hematopoietic stem cell transplantation for patients with acute...

At the 2023 Great Debates &...

04/25/2023

Oncology

Cathy Eng, MD, Vanderbilt-Ingram Cancer Center

Videos

Clinical Trials in Treatments for Anal Cancer

04/20/2023

At the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting, Cathy Eng, MD, offered her perspectives on the current and upcoming clinical trials for treatments of anal cancer.

At the 2023 Great Debates and...

04/20/2023

Oncology

Recent News

News

Addition of Toripalimab to First-Line Chemotherapy Improves Survival for Patients With Extensive-Stage Small Cell Lung Cancer

11/19/2024

Stephanie Holland ;

Results from the phase 3 EXTENTORCH trial demonstrated that the addition of toripalimab to first-line chemotherapy significantly improved survival among patients with extensive-stage small cell lung cancer.

Results from the phase 3...

11/19/2024

Oncology

News

Adjuvant Chemotherapy Followed by Radiation May Benefit Patients With High-Risk Endometrial Cancer

11/19/2024

Allison Casey ;

According to a phase 2 trial, adjuvant docetaxel-cisplatin followed by radiation therapy may benefit patients with high-risk endometrial cancer.

According to a phase 2 trial,...

11/19/2024

Oncology

News

Robotic Laparoscopy May Have Easier Recovery For Patients With Early-Stage, Low Risk Endometrial Cancer

11/19/2024

Allison Casey ;

According to a randomized clinical trial, there may be benefits to inflammation processes, tissue damage, stress and recovery time with robotic laparoscopy for early-stage endometrial cancer compared to conventional laparoscopy.

According to a randomized...

11/19/2024

Oncology

News

UGN-102 Chemoablation as TURBT Alternative for Patients With Recurrent Low-Grade Non-Muscle Invasive Bladder Cancer

11/19/2024

Stephanie Holland ;

According to results from the phase 3 ENVISION trial, chemoablation with UGN-102 demonstrates clinical promise as an alternative to standard-of-care transurethral resection of the bladder tumor for patients with recurrent low-grade...

According to results from the...

11/19/2024

Oncology

News

Tumor Mutational Status May Predict Recurrence, Survival Patterns for Patients With Early-Stage Non-Small Cell Lung Cancer

11/18/2024

Stephanie Holland ;

According to results from a retrospective analysis, tumor mutational status can potentially predict recurrence and survival patterns for patients with surgically resected, stage I non-small cell lung cancer.

According to results from a...

11/18/2024

Oncology

News

FDA Grants Approval to Revumenib for Patients With R/R Acute Leukemia With KMT2A Translocation

11/17/2024

On November 15, 2024, the FDA approved menin inhibitor revumenib for adult and pediatric patients 1 year and older with relapsed/refractory acute leukemia with KMT2A translocation.

On November 15, 2024, the FDA...

11/17/2024

Oncology

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology